Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Woolley

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Advances in Therapy|June 10, 2022
The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United StatesMichael Woolley, Erin E Cook, Fan Mu, et al.
Managed Care Interface|October 5, 2006
Comparison of costs associated with the use of etanercept, infliximab, and adalimumab for the treatment of rheumatoid arthritisMichael F Bullano, Brian J McNeeley, Yanni F Yu, et al.
The American Journal of Managed Care|March 16, 2016
LDL cholesterol response and statin adherence among high-risk patients initiating treatmentSuma Vupputuri, Peter J Joski, Ryan Kilpatrick, et al.
Lancet (London, England)|January 10, 2006
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trialStephen Tyring, Alice Gottlieb, Kim Papp, et al.
Drugs & Aging|March 16, 2006
Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studiesMichael H Schiff, Elaine B Yu, Michael E Weinblatt, et al.
The American Journal of the Medical Sciences|June 4, 2014
Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart diseaseChristopher M Gamboa, Monika M Safford, Emily B Levitan, et al.
The Journal of Rheumatology|July 18, 2008
Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA TrialXavier Le Loët, Dan Nordström, Manuel Rodriguez, et al.
Cutis|May 16, 2007
Etanercept improves psoriatic arthritis patient-reported outcomes: results from EDUCATEEllen H Frankel, Bruce E Strober, Jeffrey J Crowley, et al.
The American Journal of Cardiology|June 4, 2013
Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010Paul Muntner, Emily B Levitan, Todd M Brown, et al.
Journal of Drugs in Dermatology : JDD|March 22, 2007
Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trialAlexa Boer Kimball, J Mark Jackson, Jeffrey M Sobell, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Advances in Therapy|June 10, 2022
The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United StatesMichael Woolley, Erin E Cook, Fan Mu, et al.
Managed Care Interface|October 5, 2006
Comparison of costs associated with the use of etanercept, infliximab, and adalimumab for the treatment of rheumatoid arthritisMichael F Bullano, Brian J McNeeley, Yanni F Yu, et al.
The American Journal of Managed Care|March 16, 2016
LDL cholesterol response and statin adherence among high-risk patients initiating treatmentSuma Vupputuri, Peter J Joski, Ryan Kilpatrick, et al.
Lancet (London, England)|January 10, 2006
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trialStephen Tyring, Alice Gottlieb, Kim Papp, et al.
Drugs & Aging|March 16, 2006
Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studiesMichael H Schiff, Elaine B Yu, Michael E Weinblatt, et al.
The American Journal of the Medical Sciences|June 4, 2014
Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart diseaseChristopher M Gamboa, Monika M Safford, Emily B Levitan, et al.
The Journal of Rheumatology|July 18, 2008
Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA TrialXavier Le Loët, Dan Nordström, Manuel Rodriguez, et al.
Cutis|May 16, 2007
Etanercept improves psoriatic arthritis patient-reported outcomes: results from EDUCATEEllen H Frankel, Bruce E Strober, Jeffrey J Crowley, et al.
The American Journal of Cardiology|June 4, 2013
Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010Paul Muntner, Emily B Levitan, Todd M Brown, et al.
Journal of Drugs in Dermatology : JDD|March 22, 2007
Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trialAlexa Boer Kimball, J Mark Jackson, Jeffrey M Sobell, et al.
Pageof 4